Skip to main content
. 2021 Feb 16;30:0963689720983786. doi: 10.1177/0963689720983786

Figure 3.

Figure 3.

SND1 functioned as an RBP for SMARCA5, and the expression of SND1 was upregulated in cervical cancer cells. (A) The binding site of SMARCA5 and SND1 was predicted by starBase. (B) The expression of SND1 in normal cervical cell line and different cervical cancer cell lines was detected by western blotting, and the quantification was performed using Image J software. n = 3. *P < 0.05, **P < 0.01, one-way ANOVA. (C) RNA pull-down assay was performed to further verify the combination of SMARCA5 and SND1. n = 3. **P < 0.01, one-way ANOVA.

ANOVA: analysis of variance; NC: negative control.